Indian Pharmacopoeia Commission

Last updated

Indian Pharmacopoeia Commission
Formation1956
Headquarters Ghaziabad, [1] Uttar Pradesh, India
Chairman [2]
P. K. Pradhan, Secretary (Health & Family Welfare), Gov of India.
Website ipc.gov.in

Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare which sets standards for all drugs that are manufactured, sold and consumed in India. [3] The set of standards are published under the title Indian Pharmacopoeia (IP) which has been modelled on and historically follows from the British Pharmacopoeia. The standards that are in effect since 1 December 2010, [4] are the Indian Pharmacopoeia 2010 (IP 2010). The Pharmacopoeia 2014 was released by Health Minister Ghulam Nabi Azad on 4 November 2013. [5] The Pharmacopoeia 2018 was released by Secretary, Ministry of Health & Family Welfare, Government of India. [5]

Contents

I.P., the abbreviation of 'Indian Pharmacopoeia' is familiar to the consumers in the Indian sub-continent as a mandatory drug name suffix. Drugs manufactured in India have to be labelled with the mandatory non-proprietary drug name with the suffix I.P.[ citation needed ] This is similar to the B.P. suffix for British Pharmacopoeia and the U.S.P. suffix for the United States Pharmacopeia.

The IPC was formed according to the Indian Drugs and Cosmetics Act of 1940 and established by executive orders of the Government of India in 1956.[ citation needed ]

History of publication

The actual process of publishing the first Pharmacopoeia started in the year 1944 under the chairmanship of Col. R. N. Chopra. The I. P. list was first published in the year 1946 and was put forth for approval. The titles are suffixed with the respective years of publication, e.g., IP 1996. The following table describes the publication history of the Indian Pharmacopoeia. [6]

EditionYearVolumesAddendum/Supplement
1st Edition1955Supplement 1960
2nd Edition1966Supplement 1975
3rd Edition19852Addendum 1989
Addendum 1991
4th Edition19962Addendum 2000
Vet Supplement 2000
Addendum 2002
Addendum 2005
5th Edition20073Addendum 2008
6th Edition20103Addendum 2012
7th Edition20144Addendum 2015
Addendum 2016
8th Edition20184Addendum 2019
Addendum 2021
9th edition2022

See also

Related Research Articles

<span class="mw-page-title-main">Pharmacopoeia</span> Book containing directions for the identification of compound medicines

A pharmacopoeia, pharmacopeia, or pharmacopoea, in its modern technical sense, is a book containing directions for the identification of compound medicines, and published by the authority of a government or a medical or pharmaceutical society.

The United States Pharmacopeia (USP) is a pharmacopeia for the United States published annually by the over 200-year old United States Pharmacopeial Convention, a nonprofit organization that owns the trademark and also owns the copyright on the pharmacopeia itself.

<span class="mw-page-title-main">Regulation of therapeutic goods</span> Legal management of drugs and restricted substances

The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as in Australia.

<span class="mw-page-title-main">Nitya Anand</span> Indian medicinal chemist (1925–2024)

Nitya Anand was an Indian medicinal chemist who was the director of Central Drug Research Institute in Lucknow from 1974 to 1984. In 2005, Indian Pharmacopoeia Commission (IPC) appointed him chairman of its scientific committee. In 2012, he was awarded the Padma Shri by the Indian government.

The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom. It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

<i>European Pharmacopoeia</i> Major multinational pharmacopoeia published by the European Union

The European Pharmacopoeia is a major regional pharmacopoeia which provides common quality standards throughout the pharmaceutical industry in Europe to control the quality of medicines, and the substances used to manufacture them. It is a published collection of monographs which describe both the individual and general quality standards for ingredients, dosage forms, and methods of analysis for medicines. These standards apply to medicines for both human and veterinary use.

<span class="mw-page-title-main">European Directorate for the Quality of Medicines & HealthCare</span> International organisation

The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a Directorate of the Council of Europe that traces its origins and statutes to the Convention on the Elaboration of a European Pharmacopoeia.

<span class="mw-page-title-main">Ministry of Health and Family Welfare</span> Cabinet ministry of Government of India

The Ministry of Health and Family Welfare, also known by its abbreviation MoHFW, is an Indian government ministry charged with health policy in India. It is also responsible for all government programs relating to family planning in India.

A specification often refers to a set of documented requirements to be satisfied by a material, design, product, or service. A specification is often a type of technical standard.

<span class="mw-page-title-main">Regulation and prevalence of homeopathy</span> Alternative medicine

Homeopathy is fairly common in some countries while being uncommon in others. In some countries, there are no specific legal regulations concerning the use of homeopathy, while in others, licenses or degrees in conventional medicine from accredited universities are required.

The Ministry of Ayush, a ministry of the Government of India, is responsible for developing education, research and propagation of traditional medicine and alternative medicine systems in India. Ayush is a name devised from the names of the alternative healthcare systems covered by the ministry: ayurveda, yoga & naturopathy, Unani, Siddha, Sowa Rigpa, and homeopathy.

The Ministry of Statistics and Programme Implementation (MoSPI) is a ministry of Government of India concerned with coverage and quality aspects of statistics released. The surveys conducted by the Ministry are based on scientific sampling methods.

Bharat stage emission standards (BSES) are emission standards instituted by the Government of India to regulate the output of air pollutants from compression ignition engines and Spark-ignition engines equipment, including motor vehicles. The standards and the timeline for implementation are set by the Central Pollution Control Board under the Ministry of Environment, Forest and Climate Change.

<span class="mw-page-title-main">Ibn Sina Academy of Medieval Medicine and Sciences</span> Indian trust

Ibn Sina Academy of Medieval Medicine and Sciences (IAMMS) is a trust registered under the Indian Trusts Act, 1882. Mohammad Hamid Ansari, former vice-chancellor of Aligarh Muslim University, Aligarh, formally inaugurated it on 21 April 2001. Department of AYUSH, Ministry of Health and Family Welfare, Government of India gave accreditation to the academy in 2004 and promoted it as 'centre of excellence' in 2008. Membership of the academy is open to anyone who has an interest in the academy's activities particularly on history of medicine and history of science. Being a charitable organization, donations to the Academy are also exempted from Income Tax under section 80G of the Income Tax Act 1961.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Schedule H is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules, 1945 introduced in 1945. These are drugs which cannot be purchased over the counter without the prescription of a qualified doctor. The manufacture and sales of all drugs are covered under the Drugs and Cosmetics Act and Rules. It is revised at times based on the advice of the Drugs Technical Advisory Board, part of the Central Drugs Standard Control Organization in the Ministry of Health and Family Welfare. The most recent schedule H (2006) lists 536 drugs from abacavir to zuclopenthixol.

Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs. In the majority of circumstances, drugs have 3 types of names: chemical names, the most important of which is the IUPAC name; generic or nonproprietary names, the most important of which are international nonproprietary names (INNs); and trade names, which are brand names. Under the INN system, generic names for drugs are constructed out of affixes and stems that classify the drugs into useful categories while keeping related names distinguishable. A marketed drug might also have a company code or compound code.

Section 309 of the Indian Penal Code criminalises attempted suicide as well as suicide assistance.

<span class="mw-page-title-main">Harkishan Singh</span> Indian pharmaceutical chemist

Harkishan Singh was Professor Emeritus at the Panjab University. He was a well recognized pharmaceutical academic, medicinal chemistry researcher and science historian. He had more than half a century experience in his respective fields to his credit. He worked at the Banaras Hindu University, University of Saugar, and the Panjab University in India, and abroad at the University of Maryland, University of Mississippi and the University of London.

The Pharmacovigilance Programme of India (PvPI) is an Indian government organization which identifies and responds to drug safety problems. Its activities include receiving reports of adverse drug events and taking necessary action to remedy problems. The Central Drugs Standard Control Organisation established the program in July 2010 with All India Institute of Medical Sciences, New Delhi as the National Coordination Centre, which later shifted to Indian Pharmacopoeia Commission in Ghaziabad on 15 April 2011.

References

  1. "Indian Pharmacopoeia Commission, Contact Us". Archived from the original on 21 May 2012. Retrieved 22 November 2011.
  2. "IPC Governing body". Archived from the original on 25 April 2012. Retrieved 22 November 2011.
  3. Indian Pharmacopoeia Commission, Official Website. About IPC, Introduction.
  4. Indian Pharmacopoeia Commission, Effective Date
  5. 1 2 "Indian Pharmacopoeia Commission (IPC) Releases Eighth Edition Of Indian Pharmacopoeia (IP) - Food, Drugs, Healthcare, Life Sciences - India". www.mondaq.com. Retrieved 25 May 2021.
  6. "Presentation on IP" (PDF). Archived from the original (PDF) on 7 August 2015. Retrieved 14 July 2016.